403 related articles for article (PubMed ID: 28488124)
1. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
[TBL] [Abstract][Full Text] [Related]
3. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
Mukae H; Ishimoto H; Sakamoto N; Hara S; Kakugawa T; Nakayama S; Ishimatsu Y; Kawakami A; Eguchi K; Kohno S
Chest; 2009 Nov; 136(5):1341-1347. PubMed ID: 19581351
[TBL] [Abstract][Full Text] [Related]
4. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
[TBL] [Abstract][Full Text] [Related]
5. Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report.
Yamada K; Asai K; Okamoto A; Watanabe T; Kanazawa H; Ohata M; Ohsawa M; Hirata K
BMC Res Notes; 2018 Jan; 11(1):34. PubMed ID: 29338781
[TBL] [Abstract][Full Text] [Related]
6. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
Girard C; Vincent T; Bessis D
Ann Dermatol Venereol; 2013 Oct; 140(10):628-34. PubMed ID: 24090894
[TBL] [Abstract][Full Text] [Related]
7. Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody.
Parperis K; Kiyani A
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301801
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the patients with interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibodies.
Hayashi M; Kikuchi T; Takada T
Clin Rheumatol; 2017 Jan; 36(1):239-240. PubMed ID: 27718019
[No Abstract] [Full Text] [Related]
9. Mycophenolate mofetil therapy for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
Tsuchiya H; Tsuno H; Inoue M; Takahashi Y; Yamashita H; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2014 Jul; 24(4):694-6. PubMed ID: 24506658
[No Abstract] [Full Text] [Related]
10. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report.
Cao M; Zhang S; Chu D; Xiao M; Liu X; Yu L; Li J; Huang Y; Fang F
BMC Pulm Med; 2020 Nov; 20(1):304. PubMed ID: 33213393
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
[TBL] [Abstract][Full Text] [Related]
13. Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.
Wu W; Guo L; Fu Y; Wang K; Zhang D; Xu W; Chen Z; Ye S
Clin Rev Allergy Immunol; 2021 Apr; 60(2):293-304. PubMed ID: 33405101
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB
Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808
[TBL] [Abstract][Full Text] [Related]
15. Progressive interstitial lung disease in hypomyopathic dermatomyositis in the COVID-19 pandemic: A case report.
Wang S; Lyu Y; Xu L; Zhang W
Int J Rheum Dis; 2023 Apr; 26(4):759-763. PubMed ID: 36502514
[TBL] [Abstract][Full Text] [Related]
16. MDA-5 dermatomyositis complicated by interstitial lung disease and cutaneous ulcers: successful treatment with corticosteroids, mycophenolate mofetil and intravenous immunoglobulin.
Stager K; Wise L
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32998908
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review.
Gil B; Merav L; Pnina L; Chagai G
Clin Rheumatol; 2016 Aug; 35(8):2125-2130. PubMed ID: 25846833
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil for interstitial lung disease in dermatomyositis.
Morganroth PA; Kreider ME; Werth VP
Arthritis Care Res (Hoboken); 2010 Oct; 62(10):1496-501. PubMed ID: 20506189
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
Huapaya JA; Silhan L; Pinal-Fernandez I; Casal-Dominguez M; Johnson C; Albayda J; Paik JJ; Sanyal A; Mammen AL; Christopher-Stine L; Danoff SK
Chest; 2019 Nov; 156(5):896-906. PubMed ID: 31238042
[TBL] [Abstract][Full Text] [Related]
20. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
